Existing bacteria and archaea still our universal common ancestor’s ribosomal hibernation defense mechanism when nutrients ...
Morning Overview on MSN
New lipid nanoparticle design aims for more targeted mRNA delivery
Researchers have developed a new lipid nanoparticle design that directs mRNA to the pancreas by exploiting the organ’s own ...
Vaccination policies must prioritize saving human lives over individual choice amid rising vaccine skepticism, asserts ...
Discusses Preliminary Phase I/II Data for SRP-1001 in FSHD1 and SRP-1003 in DM1 March 25, 2026 8:30 AM EDT Anupam Rama - JPMorgan Chase & Co, Research Division Konstantinos Biliouris - Oppenheimer & ...
Ionis Pharmaceuticals is dramatically lowering the price of its blockbuster hopeful Tryngolza (olezarsen) as it prepares to ...
First new preparedness strategy since 2011 focuses on a range of threats and includes funding for a new ‘biosecurity hub’ ...
Stocktwits on MSN
SRPT stock clocks highest daily gain in nearly 8 years after rare muscle disorders study data but Wall Street's not wholly convinced
Oppenheimer analyst Kostas Biliouris, meanwhile, said Sarepta's data in the programs "appear promising." ・The firm now awaits ...
The neurologist's consulting room has always been a place of retrospect. Symptoms presented, decline charted, management ...
A new nanoparticle design directs mRNA vaccines to lymph nodes. The strategy reduced off-target delivery, maintained immune ...
A little change in the cycle that produces hair could tip the scales toward either healthy, continued hair growth or slow, ...
Discover how a new method for measuring iron flux helps scientists to rapidly identify high-quality cells for use in ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today shared the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results